clopidogrel

Latest stories

13d
Business Wire
Global Stroke Epidemiology and Patient-Based Market Report 2015-2024 - Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug AnalysisISCHEMIC STROKE - Market Overview and Trends - Market Definition and Methodol
Global Stroke Epidemiology and Patient-Based Market Report 2015-2024 - Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug Analysis
Business Wire / Posted 13 days ago
ISCHEMIC STROKE - Market Overview and Trends - Market Definition and Methodology - Brilinta (ticagrelor) - Plavix (clopidogrel) - Xarelto (rivaroxaban) - Primary Research Methodology TREATMENT: ISCHEMIC STROKE - Primary Research... Read more
10 related stories
26d
heraldscotland
Doctor who chaired NHS heart disease group linked to major drug firmsblood clots. Bristol-Myers Squibb, in partnership with Sanofi Aventis, markets
Doctor who chaired NHS heart disease group linked to major drug firms
heraldscotland / Posted 26 days ago
blood clots. Bristol-Myers Squibb, in partnership with Sanofi Aventis, markets a tablet-based treatment for ACS called Clopidogrel. Both companies appeared on his register of interest. So too was Eli Lilly and Co, which is linked to the... Read more
27d
News-Medical-Net
New study to examine genomics of anti-platelet therapy after coronary interventionsstudy. Twenty nine medical centers are now participating with more to be added
New study to examine genomics of anti-platelet therapy after coronary interventions
News-Medical-Net / Posted 27 days ago
study. Twenty nine medical centers are now participating with more to be added soon. The randomized comparison of Plavix (clopidogrel bisulfate) and Brilinta (ticagrelor) was launched by Mayo Clinic Center for Individualized Medicine and the... Read more
29d
Business Wire
Cerenis Therapeutics: Cash Position and Revenue for the 1st Semester of 2016receptor family including the P2Y12 receptor which is the target of successful
Cerenis Therapeutics: Cash Position and Revenue for the 1st Semester of 2016
Business Wire / Posted 29 days ago
receptor family including the P2Y12 receptor which is the target of successful drugs such as the anti-thrombotic agent Clopidogrel (Plavix®). In preclinical studies CER-209 promotes HDL recognition by the liver and increase the activity of... Read more
29d
Business Wire
Cerenis Therapeutics : Chiffre d’affaires et position de trésorerie du 1er semestre 2016récepteurs P2Y, qui comprend notamment le récepteur P2Y12, cible de médicaments
Cerenis Therapeutics : Chiffre d’affaires et position de trésorerie du 1er semestre 2016
Business Wire / Posted 29 days ago
récepteurs P2Y, qui comprend notamment le récepteur P2Y12, cible de médicaments à succès tels que l’agent anti-thrombotique Clopidogrel (Plavix®). Les études précliniques ont montré que le CER-209 agit sur la dernière étape de la voie RLT, augmente... Read more
99 related stories

People in this news